维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="PESKIND E"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cerebrospinal fluidand plasma insulin levels in Alzheimer's disease: relationshipto severity of dementia and apolipoprotein E genotype 显示文摘	Craft S Peskind E Schwartz MW	1998	Neurology1998，50，1：	1
2	Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures 显示文摘	Galasko DR Peskind E Clark CM	2012	ArchNeurol2012，69，7：	1
3	Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype显示文摘	Craft S Peskind E Schwartz MW	1998	Neurology1998，50，：	1
4	Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans显示文摘	Schwartz MW Peskind E Raskind M	1996	Nat Med1996，2，：	1
5	CSF muhianalyte profile distinguishes Alzheimer and Parkinson diseases显示文摘	Zhang J Sokal I Peskind E R Quinn J F Jankovie J Kenney C	2008	Am J Clin Pathol2008，129，：	1
6	Cerebrospinal fluid leptin levels: relationship to plas ma leves and to adiposity in humans 显示文摘	SCHWARTZ M W PESKIND E RASKIND M	1996	Nat Med1996，2，5：	1
7	CSF multianalyte profile distinguishes alzheimer and Parkinson diseases显示文摘	Zhang J Sokal I Peskind E R	2008	Am J Clin Pathol2008，129，4：	1
8	Increased galanin receptor occupancy in Alzheimer's disease显示文摘	McMillan P J Peskind E Raskind M A	2004	Neurobiol Aging2004，25，10：	1
9	Treatment of agitation in AD:a randomized,placebo-controlled clinical trial显示文摘	Teri L Logsdon RG Peskind E		0，，：	1
10	Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial 显示文摘	Pomara N Ott BR Peskind E	2007	Alzheimer Dis Assoc Disord2007，21，1：	1
11	Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans 显示文摘	Schwarz M W Peskind E Raskind M	1996	Nat Med1996，2，：	1
12	Memantine treatment in mild to moderate Alzheimer's disease:a 24-week randomized, controlled trial 显示文摘	PESKIND E R POTKIN S G POMARA N	2006	Am J Geriatr Psychiatry2006，14，6：	1
13	Treatment of agitation in AD:a randomized,placebo-controlled clinical trial显示文摘	Logsdon RG Peskind E	2000	Neurology2000，55，：	1
14	Memantine treatment in mild to moderate Alzheimer disease:a 24 week randomized,controlled trial显示文摘	Peskind E R Potkin S G Pomara N	2006	Am J Geriatr Psychiatry2006，14，8：	1
15	Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study显示文摘	G Li R Higdon W A. Kukull E Peskind K Van Valen Moore D Tsuang G van Belle W McCormick J D. Bowen L Teri G D. Schellenberg E B. Larson	2004	Neurology2004，，9：	1
16	Cerebrospinal fluid and plasma insulin levels in Alzheimer′s disease:relationship to severity of dementia and apolipoprotein E genotype显示文摘	Craft S Peskind E Schwartz MW		0，，：	1
17	Cerebrespinal fluid leptin levels:relationship to plasma levels and to adiposity in humans 显示文摘	Schwartz MW Peskind E Raskind M	1996	Nat Med1996，2，5：	1
18	Changesin the sleep and waking EEGs of nondemented and de-mented elderly subjects显示文摘	Prinz P N Peskind E R Vitaliano P P	1982	J Am Geriatr Soc1982，30，2：	1
19	CSF multiana- lyte profile distinguishes Alzheimer and Parkinson diseases显示文摘	ZHANG J SOKAL I PESKIND E R	2008	Am J Clin Pathol2008，129，4：	1
20	Memantine treatment of cognitive symptoms in mild to moderate Alzheimer's disease: secondary analyses from a placepo- controlled randomized trial 显示文摘	POMARA N OTT B R PESKIND E	2007	Alzheimer Dis Assoc Disord2007，21，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示